We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. Read more about our Privacy Policy.

I got it!

Event
21 Sep 2016
Education

Webinar topic on FDA's Guidance on Financial Disclosure by Clinical Investigators

Clinical Investigators

Overview:  
This webinar will provide an overview and guidance to firms that are either going through or preparing to go through clinical trials and working with clinical investigators.

Earlier this year (Spring 2011), FDA released its draft guidance to replace its current guidance on disclosure of financial interests held by clinical investigators. The draft guidance reflects the changing landscape both within and outside FDA regarding transparency of financial interests. 

Areas Covered in the Session:
Review proposed changes to the 2011 released draft guidance
Clarification on definition of sponsor
Understand FDA’s clear actions that can and will be taken regarding refuse to file a marketing application
Learn how to submit financial disclosure information to FDA
Why FDA is expounding on due diligence and its significance 
Timing of data collection and purpose
Understand how financial information should be disclosed to FDA
Update regarding financial disclosure questionnaires 
Time period covered by regulations
Clarification on covered clinical study
Factors for FDA review of disclosed financial interests

Who Will Benefit: 
The employees who will benefit include: All levels of management and departmental representatives and those who desire a better understanding with FDA’s draft guidance on financial disclosure by clinical investigators, including:
Regulatory Affairs
Clinical Affairs
Investigators
Quality and Compliance
Marketing & Sales 
Distributors/Authorized Representatives
Legal Counsel
Consultants

Speaker Profile:
David R. Dills , Global Regulatory Affairs & Compliance Consultant, has an accomplished record with more than 26 years of experience within regulatory affairs, compliance and quality consultative services for early-stage/established Class I/II/III medical devices, IVDs, and bio/pharmaceutical manufacturers on the global landscape. 

Contact Detail:

Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: [email protected]
http://www.compliance4all.com/
Event Link : http://bit.ly/2aa1gix
Twitter Follow us – https://twitter.com/compliance4all
Facebook Like us – https://www.facebook.com/Compliance4all
Pinterest - https://in.pinterest.com/compliance4all/

When

21 Sep 2016 @ 10:00 am

21 Sep 2016 @ 11:00 am

Duration: 1 hours


Where

Online Event

Fremont

United States


Language

English en


Organised by

NetZealous (deactivated)

Featured Events in Culture

Other Events in Culture

Executive MBA event in Brussels

Belgium, 16 May 2024

Similar Webinars in Culture

Rural Innovation Ecosystems

Webinar, 30 May 2024

Recent Publications in Culture

Terminology of European education and training policy

Guide, Apr 2024, cedefop.europa.eu

Innover en faveur de la jeunesse

Report, Apr 2024, anru.fr

Featured Events